Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Talus Bio turns previously undruggable transcription factors into therapeutic targets by directly measuring and modulating the cellular regulome. The company’s MARMOT platform combines functional…

Talus Bio turns previously undruggable transcription factors into therapeutic targets by directly measuring and modulating the cellular regulome. The company’s MARMOT platform combines functional…
Founded: 2020
Headquarters: Seattle, WA
Focus: Drug discovery targeting transcription factors via regulome profiling
Platform: MARMOT native regulome profiling (functional proteomics + ML + chemistry)
Recent financing: Seed+ round led by Two Bear Capital (announced Aug 20, 2024)
Drug discovery for diseases driven by genome regulators (oncology, rare disease, immune dysfunction, neurodegeneration).
2020
Biotechnology Research
9750000
Seed round closed; reported raise of $9.75M with participation from investors including NFX and Y Combinator.
11200000
Seed+ financing announced with participation from WRF Capital, NFX, YC Continuity Fund, FundersClub VC, and BoxOne Ventures.
“Two Bear Capital led the Aug 20, 2024 Seed+ round; earlier investors include NFX and Y Combinator.”
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
81,000+
Open Roles
4,600+
New This Week
| Company |
|---|